Care.com Inc (NASDAQ:CRCM) fell 0.4% on Monday . The company traded as low as $11.27 and last traded at $11.36, with a volume of 182,616 shares changing hands. The stock had previously closed at $11.41.

A number of brokerages have recently weighed in on CRCM. JPMorgan Chase & Co. restated a “hold” rating on shares of Care.com in a report on Thursday, June 30th. Morgan Stanley restated a “hold” rating on shares of Care.com in a report on Thursday, June 30th. Needham & Company LLC restated a “buy” rating and issued a $12.00 price objective (up from $9.00) on shares of Care.com in a report on Thursday, June 30th. Finally, Zacks Investment Research lowered shares of Care.com from a “buy” rating to a “hold” rating in a report on Tuesday, June 28th.

The company has a 50 day moving average of $9.26 and a 200 day moving average of $7.09. The company’s market cap is $362.03 million.

In other news, major shareholder Matrix Partners Vii Lp Et Al sold 3,684,645 shares of the company’s stock in a transaction on Wednesday, June 29th. The shares were sold at an average price of $8.25, for a total value of $30,398,321.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Sheila Lirio Marcelo sold 10,440 shares of the company’s stock in a transaction on Monday, June 13th. The shares were sold at an average price of $8.70, for a total transaction of $90,828.00. Following the completion of the transaction, the chief executive officer now owns 844,904 shares of the company’s stock, valued at $7,350,664.80. The disclosure for this sale can be found here.

Care.com, Inc is an online marketplace for finding and managing family care. The Company has approximately 18.4 million members, including over 10.3 million families and approximately 8.1 million caregivers, spanning over 20 countries. Its consumer matching solutions allow families to search for, qualify, vet, connect with and select caregivers.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.